Eilean Therapeutics
Manufacturing · Delaware, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8 The Grn Ste 8183, Dover, Delaware, 199...Website
www.eileanther.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Eilean Therapeutics
Eilean Therapeutics is a small molecule oncology drug discovery company focused on developing pan-variant therapies for hematological cancers. The company aims to target escape mutations and the major drivers of cancer resistance, providing first and best in class medicines. Their innovative approach seeks to overcome the limitations of current oncology therapeutics. Eilean Therapeutics is dedicated to defeating cancer and advancing treatments for patients with hematologic malignancies.Explore more
Popular SearchesEilean TherapeuticsEilean Therapeutics LLCSIC Code 28,283NAICS Code 32,325Show moreEilean Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eilean Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Eilean Therapeutics has new funding data
Eilean Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Eilean Therapeutics
Check out if Eilean Therapeutics is spiking on competitors!
Earning: See what the market has to say on Eilean Therapeutics recently announced quarterly report
Check if Eilean Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Eilean Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Eilean Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Eilean Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Eilean Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eilean Therapeutics.
Eilean Therapeutics Tech Stack
A closer look at the technologies used by Eilean Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Research & Development, Legal Affairs, Medical Research
Mergers & Acquisitions (M&A)
Eilean Therapeutics News & Media
Eilean Therapeutics to Present First-in-Class, Wild-Type-Sparing JAK2-JH2/V617F Inhibitor ZE74-0282 at ASH 2025 and Initiate Clinical Studies in December 2025
DOVER, Del., Nov. 6, 2025 /PRNewswire/ -- Eilean Therapeutics LLC, a biotechnology company developing next-generation precision medicines for cancer and immune-inflammatory diseases, today announced the upcoming presentation of preclinical data for its first-in-class, wild-type–sparing...Eilean Therapeutics Presents First-in-Class MALT1 Degrader TE205 Demonstrating In Vivo Efficacy in Ulcerative Colitis at the 4th International Conference on Microbiology and Immunology
DOVER, Del., Nov. 4, 2025 /PRNewswire/ -- Eilean Therapeutics LLC, a biopharmaceutical company dedicated to developing best-in-class and first-in-class small-molecule therapies targeting genetic escape mutations in cancer and advancing innovative treatments for chronic inflammatory and...Eilean Therapeutics Presents Novel, Selective, Brain-Permeable CDK2 Inhibitor for Treatment of CCNE1-Dependent Cancers
DOVER, Del., Oct. 16, 2025 /PRNewswire/ -- Eilean Therapeutics LLC, a biopharmaceutical company dedicated to discovering and developing best-in-class and first-in-class therapies targeting escape mutations in hematologic malignancies and solid tumors, today announced the presentation of...EiIean Therapeutics Presents Novel Wild-Type Sparing, Reversible Pan-EGFR Inhibitor (ZE77-0273) with Broad Activity Against Resistance Mutations in EGFR-Mutant NSCLC at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
DOVER, Del., Oct. 13, 2025 /PRNewswire/ -- Eilean Therapeutics LLC, a biopharmaceutical company dedicated to discovering and developing best-in-class and first-in-class small molecule inhibitors targeting escape mutations in hematologic malignancies and solid tumors, today announced the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eilean Therapeutics
Sign Up For FreeTo access detailed company insights
Eilean Therapeutics is a small molecule oncology drug discovery company focused on developing pan-variant therapies for hematological cancers. The company aims to target escape mutations and the major drivers of cancer resistance, providing first and best in class medicines. Their innovative approach seeks to overcome the limitations of current onc... Read More
